AU2002213755A1 - A vaccine for acids and its preparation and use - Google Patents
A vaccine for acids and its preparation and useInfo
- Publication number
- AU2002213755A1 AU2002213755A1 AU2002213755A AU1375502A AU2002213755A1 AU 2002213755 A1 AU2002213755 A1 AU 2002213755A1 AU 2002213755 A AU2002213755 A AU 2002213755A AU 1375502 A AU1375502 A AU 1375502A AU 2002213755 A1 AU2002213755 A1 AU 2002213755A1
- Authority
- AU
- Australia
- Prior art keywords
- vaccine
- acids
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN00123487 | 2000-08-18 | ||
CN00123487A CN1339320A (en) | 2000-08-18 | 2000-08-18 | AIDS vacuum and its preparing method and use |
PCT/CN2001/001190 WO2002026253A1 (en) | 2000-08-18 | 2001-07-20 | A vaccine for acids and its preparation and use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002213755A1 true AU2002213755A1 (en) | 2002-04-08 |
Family
ID=4589907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002213755A Abandoned AU2002213755A1 (en) | 2000-08-18 | 2001-07-20 | A vaccine for acids and its preparation and use |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1339320A (en) |
AU (1) | AU2002213755A1 (en) |
WO (1) | WO2002026253A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004005186B3 (en) * | 2004-02-02 | 2005-10-13 | Krka Tovarna Zdravil, D.D. | Process for the preparation of purified ciprofloxacin |
CA2558733C (en) * | 2004-02-06 | 2016-04-19 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual |
CN101914143A (en) * | 2010-08-19 | 2010-12-15 | 清华大学 | HIV-1 membrane fusion inhibitor and application thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5013548A (en) * | 1987-09-08 | 1991-05-07 | Duke University | Production of antibodies to HIV |
FR2671554A1 (en) * | 1991-01-11 | 1992-07-17 | Clonatec Sa | HEPATITIS B VIRUS-BASED HBC ANTIGEN SYNTHETIC PEPTIDES, THEIR USE IN THE DETECTION OF VIRUS INFECTION AND VACCINATION AGAINST HEPATITIS B. |
IT1254360B (en) * | 1992-05-11 | 1995-09-14 | San Romanello Centro Fond | IMMUNOLOGICALLY HOMOLOGICAL EPITOPES OF HLA AND VIRUS HIV PROTEINS. |
AU7568794A (en) * | 1993-08-20 | 1995-03-21 | St. Luke's-Roosevelt Hospital Center | Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof |
US7018637B2 (en) * | 1998-02-23 | 2006-03-28 | Aventis Pasteur, Inc | Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
-
2000
- 2000-08-18 CN CN00123487A patent/CN1339320A/en active Pending
-
2001
- 2001-07-20 WO PCT/CN2001/001190 patent/WO2002026253A1/en active Application Filing
- 2001-07-20 AU AU2002213755A patent/AU2002213755A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002026253A1 (en) | 2002-04-04 |
CN1339320A (en) | 2002-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002336760A1 (en) | Mutable vaccines | |
PL392363A1 (en) | Vaccine formulation | |
AU2001280188A1 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
AU1591402A (en) | Vaccine | |
AU2001235506A1 (en) | Dermatological use and a dermatological preparation | |
AU2001273761A1 (en) | Preparation of (r)-2-alkyl-3-phenylpropionic acids | |
AUPQ520800A0 (en) | Prime-boost vaccination strategy | |
AU2002214978A1 (en) | Beta-Thio-amino acids | |
AU5977700A (en) | Vaccines | |
AU2001273644A1 (en) | Disposable mattress portion | |
AUPQ948800A0 (en) | A vaccine strategy | |
AU2001241771A1 (en) | Use of avocado-soybean unsaponifiable preparations | |
AU6158700A (en) | Vaccine | |
AUPR030800A0 (en) | Immunomodulatory preparation | |
AU2001278323A1 (en) | Modified sialic acid vaccines | |
AU2002213755A1 (en) | A vaccine for acids and its preparation and use | |
AU2002249823A1 (en) | Acne vaccine | |
AU2001267541A1 (en) | Vaccine composition | |
AU2001241187A1 (en) | Sustained release oral preparations | |
AU2002222139A1 (en) | Hcv vaccines | |
AU2001252921A1 (en) | A glycopeptide and preparation thereof | |
AU5811600A (en) | Vaccine | |
AU2001257100A1 (en) | Nalpha, nomega-dialkyl aminomethylenephosphonic acids and use thereof | |
AU2002223398A1 (en) | A vaccine for influenza virus and its preparation | |
AU2001288795A1 (en) | Eia vaccine and diagnostic |